• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高甘油三酯血症在动脉粥样硬化中的作用。

The role of hypertriglyceridemia in atherosclerosis.

作者信息

Le Ngoc-Anh, Walter Mary F

机构信息

Emory Lipid Research Laboratory, Atlanta Veterans' Affairs Medical Center, 1670 Clairemont Road, Room 4A187, Decatur, GA 30033, USA.

出版信息

Curr Atheroscler Rep. 2007 Aug;9(2):110-5. doi: 10.1007/s11883-007-0006-7.

DOI:10.1007/s11883-007-0006-7
PMID:17877919
Abstract

Atherosclerosis is a chronic disease associated with accumulation of lipids in lesions along blood vessels, leading to the occlusion of blood flow. Much of the focus has been on the role of low-density lipoprotein (LDL), and of oxidatively modified LDL, in the initiation and progression of this disease. LDL is in fact a metabolic end-product of the triglyceride-rich lipoproteins (ie, very-low density lipoproteins). Over the years, univariate analyses have implicated triglycerides as a contributor in atherosclerosis. However, depending on the studies, the significance of this relationship is either reduced or nullified when other co-variates are taken into account. This review summarizes more recent data that support the role of triglyceride-rich lipoproteins in the atherosclerotic process, both in the fasted as well as in the postprandial state.

摘要

动脉粥样硬化是一种慢性疾病,与血管病变处脂质积聚有关,可导致血流阻塞。人们大多关注低密度脂蛋白(LDL)以及氧化修饰的LDL在该疾病发生和发展中的作用。事实上,LDL是富含甘油三酯的脂蛋白(即极低密度脂蛋白)的代谢终产物。多年来,单变量分析表明甘油三酯是动脉粥样硬化的一个促成因素。然而,根据不同研究,当考虑其他协变量时,这种关系的重要性要么降低,要么消失。本综述总结了更多最新数据,这些数据支持富含甘油三酯的脂蛋白在空腹和餐后状态下的动脉粥样硬化过程中的作用。

相似文献

1
The role of hypertriglyceridemia in atherosclerosis.高甘油三酯血症在动脉粥样硬化中的作用。
Curr Atheroscler Rep. 2007 Aug;9(2):110-5. doi: 10.1007/s11883-007-0006-7.
2
[Clinical science relating atherosclerotic diseases and hypertriglyceridemia].[与动脉粥样硬化疾病和高甘油三酯血症相关的临床科学]
Nihon Rinsho. 2013 Sep;71(9):1546-51.
3
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: clinical aspects.富含甘油三酯的脂蛋白在动脉粥样硬化血栓形成中的病理生理学:临床方面
Clin Cardiol. 1999 Jun;22(6 Suppl):II15-20. doi: 10.1002/clc.4960221404.
4
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk.被遗忘的脂质:甘油三酯、残粒胆固醇与动脉粥样硬化性心血管疾病风险。
Endocr Rev. 2019 Apr 1;40(2):537-557. doi: 10.1210/er.2018-00184.
5
The adaptor protein PID1 regulates receptor-dependent endocytosis of postprandial triglyceride-rich lipoproteins.衔接蛋白 PID1 调节餐后富含甘油三酯的脂蛋白的受体依赖性内吞作用。
Mol Metab. 2018 Oct;16:88-99. doi: 10.1016/j.molmet.2018.07.010. Epub 2018 Jul 30.
6
A risk factor for atherosclerosis: triglyceride-rich lipoproteins.动脉粥样硬化的一个风险因素:富含甘油三酯的脂蛋白。
Adv Intern Med. 2001;47:111-36.
7
Hypertriglyceridemia and atherosclerosis.高甘油三酯血症与动脉粥样硬化。
Lipids Health Dis. 2017 Dec 6;16(1):233. doi: 10.1186/s12944-017-0625-0.
8
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis: cellular aspects.富含甘油三酯的脂蛋白在动脉粥样硬化血栓形成中的病理生理学:细胞层面
Clin Cardiol. 1999 Jun;22(6 Suppl):II7-14. doi: 10.1002/clc.4960221403.
9
[Determination of potentially atherogenic triglyceride-rich lipoprotein particles].[富含甘油三酯的潜在致动脉粥样硬化脂蛋白颗粒的测定]
Klin Wochenschr. 1990;68 Suppl 22:38-42.
10
Two different views of the relationship of hypertriglyceridemia to coronary heart disease. Implications for treatment.关于高甘油三酯血症与冠心病关系的两种不同观点。对治疗的启示。
Arch Intern Med. 1992 Jan;152(1):28-34.

引用本文的文献

1
Macromolecular Interactions of Lipoprotein Lipase (LPL).脂蛋白脂肪酶(LPL)的大分子相互作用。
Subcell Biochem. 2024;104:139-179. doi: 10.1007/978-3-031-58843-3_8.
2
Cordycepin for Health and Wellbeing: A Potent Bioactive Metabolite of an Entomopathogenic Medicinal Fungus and Its Nutraceutical and Therapeutic Potential.蛹虫草素的健康与福祉:一种昆虫病原药用真菌的强效生物活性代谢产物及其营养保健品和治疗潜力。
Molecules. 2020 Jun 12;25(12):2735. doi: 10.3390/molecules25122735.
3
The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage.

本文引用的文献

1
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?心血管疾病中的脂蛋白氧化:主要元凶还是无辜旁观者?
J Exp Med. 2006 Apr 17;203(4):813-6. doi: 10.1084/jem.20060218. Epub 2006 Apr 10.
2
Phospholipid transfer activity of microsomal triacylglycerol transfer protein is sufficient for the assembly and secretion of apolipoprotein B lipoproteins.微粒体三酰甘油转移蛋白的磷脂转移活性足以支持载脂蛋白B脂蛋白的组装和分泌。
J Biol Chem. 2006 Apr 21;281(16):11019-27. doi: 10.1074/jbc.M512823200. Epub 2006 Feb 13.
3
Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?
螺旋状脂蛋白脂肪酶的结构揭示了脂肪酶储存的一个出人意料的变化。
Proc Natl Acad Sci U S A. 2020 May 12;117(19):10254-10264. doi: 10.1073/pnas.1916555117. Epub 2020 Apr 24.
4
Ulmus macrocarpa Hance modulates lipid metabolism in hyperlipidemia via activation of AMPK pathway.榆树通过激活 AMPK 通路调节高血脂症的脂代谢。
PLoS One. 2019 May 23;14(5):e0217112. doi: 10.1371/journal.pone.0217112. eCollection 2019.
5
Lipingshu capsule improves atherosclerosis associated with lipid regulation and inflammation inhibition in apolipoprotein E-deficient mice.力平脂胶囊可改善载脂蛋白 E 缺乏小鼠的动脉粥样硬化,调节血脂和抑制炎症。
Lipids Health Dis. 2018 Jul 31;17(1):182. doi: 10.1186/s12944-018-0823-4.
6
Yirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice.益瑞胶囊通过改善脂代谢和减轻载脂蛋白 E 缺乏小鼠的炎症反应缓解动脉粥样硬化。
Nutrients. 2018 Jan 29;10(2):142. doi: 10.3390/nu10020142.
7
Influence of Apolipoprotein E on the Lipid Profile and Postprandial Triglyceride Levels in Brazilian Postmenopausal Women With Artery Disease.载脂蛋白E对患有动脉疾病的巴西绝经后妇女血脂谱及餐后甘油三酯水平的影响。
Clin Med Insights Cardiol. 2017 Sep 21;11:1179546817731110. doi: 10.1177/1179546817731110. eCollection 2017.
8
Discordant Lipid Pattern and Carotid Atherosclerotic Plaque. Importance of Remnant Cholesterol.不一致的血脂模式与颈动脉粥样硬化斑块。残余胆固醇的重要性。
Arq Bras Cardiol. 2017 Jun;108(6):526-532. doi: 10.5935/abc.20170069.
9
Effects of Subcutaneous Injection MnO Micro- and Nanoparticles on Blood Glucose Level and Lipid Profile in Rat.皮下注射MnO微米和纳米颗粒对大鼠血糖水平和血脂谱的影响。
Iran J Med Sci. 2016 Nov;41(6):518-524.
10
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs.当前血脂异常的治疗:非他汀类药物和新型药物的不断演变的作用。
Drugs. 2015 Jul;75(11):1201-28. doi: 10.1007/s40265-015-0429-3.
载脂蛋白A5是富含甘油三酯脂蛋白的新型调节剂吗?
Ann Med. 2006;38(1):2-10. doi: 10.1080/07853890500407488.
4
The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma.动脉粥样硬化的氧化修饰假说:血浆中氧化型低密度脂蛋白和残余脂蛋白致动脉粥样硬化作用的比较
Clin Chim Acta. 2006 May;367(1-2):36-47. doi: 10.1016/j.cca.2005.12.013. Epub 2006 Jan 30.
5
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.载脂蛋白C-III和A-V作为极低密度脂蛋白甘油三酯及载脂蛋白B-100动力学的预测指标。
Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):590-6. doi: 10.1161/01.ATV.0000203519.25116.54. Epub 2006 Jan 12.
6
Give me A5 for lipoprotein hydrolysis!给我用于脂蛋白水解的A5!
J Clin Invest. 2005 Oct;115(10):2694-6. doi: 10.1172/JCI26712.
7
ApoA-V: the regulation of a regulator of plasma triglycerides.载脂蛋白A-V:血浆甘油三酯调节因子的调节作用
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1097-9. doi: 10.1161/01.ATV.0000167518.27125.b1.
8
Comparison of the relation of triglyceride-rich lipoproteins and muscular artery compliance in healthy women versus healthy men.
Am J Cardiol. 2005 May 1;95(9):1049-54. doi: 10.1016/j.amjcard.2004.12.057.
9
Pitavastatin inhibits remnant lipoprotein-induced macrophage foam cell formation through ApoB48 receptor-dependent mechanism.匹伐他汀通过载脂蛋白B48受体依赖性机制抑制残余脂蛋白诱导的巨噬细胞泡沫细胞形成。
Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):424-9. doi: 10.1161/01.ATV.0000152632.48937.2d. Epub 2004 Dec 9.
10
Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice.抑制甘油三酯合成作为肥胖症的治疗策略:来自DGAT1基因缺陷小鼠的经验教训。
Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):482-6. doi: 10.1161/01.ATV.0000151874.81059.ad. Epub 2004 Nov 29.